Stocks and Investing Stocks and Investing
Tue, May 7, 2024

Edward Nash Maintained (TVTX) at Strong Buy with Increased Target to $18 on, May 7th, 2024


Published on 2024-10-28 11:03:03 - WOPRAI, Edward Nash
  Print publication without navigation


Edward Nash of Canaccord Genuity, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Increased Target from $15 to $18 on, May 7th, 2024.

Edward has made no other calls on TVTX in the last 4 months.



There are 4 other peers that have a rating on TVTX. Out of the 4 peers that are also analyzing TVTX, 3 agree with Edward's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vamil Divan of "Guggenheim" Downgraded from Strong Buy to Hold on, Wednesday, March 27th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $9 on, Friday, February 16th, 2024
  • Nicole Gabreski of "Piper Sandler" Maintained at Hold with Increased Target to $11 on, Thursday, January 18th, 2024


This is the rating of the analyst that currently disagrees with Edward


  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $13 on, Wednesday, April 17th, 2024
Contributing Sources